/PRNewswire/ EirGenix Inc. (6589. TT) announced today that its trastuzumab biosimilar medicine (EG12014) which their commercial partner Sandoz plans to.
TAIPEI, Nov. 23, 2023 /PRNewswire/ EirGenix Inc. (6589. TT) announced today that its trastuzumab Biosimilar medicine (EG12014) which their commercial .
/PRNewswire/ EirGenix, Inc. (6589.TT) announced on 28th of April that it has completed the phase 1 clinical trial (EGC101) of its second breast cancer.
Exhibition visitors surpass 100,000 people over 4 days BIO Asia-Taiwan success a testament to Taiwan's booming biotechnology industry TAIPEI, Aug. 8, 2022 /PRNewswire/ BIO Asia-Taiwan 2022, held at the TaiNEX 2 Exhibition Center, Nangang, Taipei, from 27-31 July, came to a successful conclusion on Sunday, 31st of July. Held in an innovative onsite-online format to encourage international participation, with the pandemic winding down crowds returned to the event in large numbers; around 1,500 people from 30 countries attended the conference and other onsite events while more than 100,000 people visited the exhibition. With Taiwan's biomedical sector continuing to grow strongly, BIO Asia-Taiwan's recent success is a testament to this growth. Living up to its theme 'Connecting the Asian Value Chain', the event provided the perfect platform for the global biotechnology community to link into Asian value and supply chains. Commenting on the significance of the gatherin